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Haemophilus ducreyi, a cause of genital ulcer disease in developing countries, appears to facilitate the
heterosexual transmission of the human immunodeficiency virus in Africa. Despite an increase in studies of
this gram-negative human pathogen, little is known about the pathogenesis of chancroid. Our studies have
shown that the lipooligosaccharides (LOS) of H. ducreyi may play an important role in ulcer formation.
Monoclonal antibody and mass spectrometric analyses identified a terminal trisaccharide present on H. ducreyi
LOS that is immunochemically similar to human paragloboside. This epitope is present on the LOS ofNeisseria
gonorrhoeae, and it may be the site of attachment for pyocin lysis. We have used pyocin, produced by
Pseudomonas aeruginosa, to select LOS variants with sequential saccharide deletions from N. gonorrhoeae. On
the basis of the similarities between N. gonorrhoeae and H. ducreyi LOS, we employed the same technique to
determine if H. ducreyi strains were susceptible to pyocin lysis. In this study, we report the generation of a
pyocin N-resistant H. ducreyi strain which synthesizes a truncated version of the parental LOS. Further studies
have shown that this H. ducreyi variant has lost the terminal LOS epitope defined by monoclonal antibody
3F11. This report demonstrates that H. ducreyi is sensitive to pyocins and that this technique can be used to
generate H. ducreyi LOS variants. Such variants could be used in comparative studies to relate LOS structure
to biologic function in the pathogenesis of chancroid.
The resurgence in studies involving the gram-negative
pathogen Haemophilus ducreyi has been stimulated by the fact
that genital ulcer disease has been shown to be a significant
contributor to human immunodeficiency virus transmission
and seroconversion (12, 30, 32). Most of the recent work with
H. ducreyi has characterized bacterial components such as
outer membrane proteins, pili, and a cytotoxin (1, 23, 29, 31).
However, the role of these components in infection remains
unknown. The high frequency of chancroid in parts of Africa
and Asia (24), where human immunodeficiency virus type 1 is
epidemic, makes it imperative to elucidate the actual events
involved in the pathogenesis of chancroid in vivo.
Our laboratory has shown that the lipooligosaccharides
(LOS) expressed by H. ducreyi may be a significant factor in the
initiation of ulcer formation (4). Immunochemical and physi-
cochemical analyses indicate that H. ducreyi and Neisseria
gonorrhoeae LOS share important components. The oligosac-
charides from both organisms contain a terminal structure
recognized by monoclonal antibody (MAb) 3F1 1, which also
binds to human paragloboside (20).
Previous work from our laboratory has used pyocins, bacte-
riocins isolated from Pseudomonas aeruginosa, to select LOS
variants from N. gonorrhoeae which have sequential deletions
in their oligosaccharide (7, 11). We have shown that the
probable LOS binding site for pyocin corresponds to the
presence of the epitope reactive with MAb 3F1 1. Structural
analyses have recently been completed on the LOS of the
pyocin survivors, and this information will be critical in relating
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LOS structure to biologic function involving the pathogenesis
of Neisseria species (11).
On the basis of the similarities between H. ducreyi and N.
gonorrhoeae LOS, we sought to determine if H. ducreyi was
pyocin susceptible and if pyocin selection could be used to
generate stable LOS variants from these organisms. Such LOS
variants would be useful in comparative experiments aimed at
understanding the role of H. ducreyi LOS in the pathogenesis
of chancroid.
MATERIALS AND METHODS
Bacteria. H. ducreyi 35000, 27722, 023233, 188, and CIP542
strains were obtained from our collection. The bacteria were
cultured on chocolate agar plates at 34°C and in 5% CO2 as
previously described (4). Any colonies resistant to pyocin lysis
were confirmed by colony morphology, Gram stain, require-
ment for X but not V factor, oxidase positivity, catalase
negativity, and the inability to ferment glucose, lactose, and
sucrose (4). The P. aeruginosa strains used for the production
of pyocins were obtained from our own collection and grown
on supplemented GC medium base as described in the gono-
coccal studies (7).
Pyocin isolation. Pyocins were isolated from P. aeruginosa
strains by the method described by Morse et al. (24).
Pyocin selection. The pyocin assay was performed on a lawn
of H. ducreyi by the procedure described previously (7). Briefly,
the organisms were harvested from an overnight growth on
chocolate agar and suspended in brain heart infusion broth and
hemin, supplemented with IsoVitaleX and fetal bovine serum.
The final concentration of bacteria was 107 CFU per ml.
Approximately 100 [L1 of each bacterial suspension was plated
onto the surface of a chocolate agar plate, and 10 p.l of each
purified pyocin preparation was spotted in a defined area on
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TABLE 1. Pyocin susceptibilities of H. ducreyi strains used
in this proposal
H. ducreyi Susceptibility to lysis by pyocin":
strain C D E F G H I J K L M N
CIP542 S R R T S R T R R S S S
27722 S R R T S R R R R R S S
188 S R R R S R S S S S S S
35000 S R R T S R T R T S S S
023233 S R R T S T R R T T S S
" Abbreviations: R, resistant; S, sensitive; T, turbid (partially sensitive).
each lawn. The plates were incubated at 35°C overnight in a
5% CO2 incubator. After 18 to 24 h, the plates were observed
for a zone of lysis where each pyocin spot was placed. In the
initial screening for pyocin sensitivity (Table 1), each strain was
scored as sensitive (S), resistant (R), or partially sensitive (T).
Colonies that were present in a zone of lysis were individually
picked and expanded for analyses.
LOS preparations. The LOS from parental and selected
pyocin survivors were purified by a modification of the method
described by Inzana (10). LOS analyzed by mass spectrometry
were isolated by the phenol-water method described by West-
phal and Jann (34).
SDS-PAGE. The LOS preparations were initially analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) on 14% acrylamide gels with 2.5% urea, as
previously described (13). Subsequent analyses were per-
formed by the tricine gel method, which provided better
resolution of the LOS banding patterns (16).
Colony blot assays. Pyocin survivors were analyzed for the
expression of the MAb 3F1 1 oligosaccharide epitope by using
colony blots as previously described (3).
Composition and linkage analysis. Prior to composition
analysis, oligosaccharide fractions from strain 188 and its
pyocin variant, 188-2, were prepared by acetic acid hydrolysis
of the LOS ("2 mg/ml) for 2 h at 100°C. Monosaccharide
compositions of the released oligosaccharide fractions from
the LOS of both strains were obtained after partial purification
on two tandem Bio-Sil TSK-125 columns (60 by 0.75 cm)
running with 50 mM pyridinium-acetate (pH 5.2) at a flow rate
of 1 ml/min. Detection was carried out by on-line refractive
index (Knauer). The partially purified oligosaccharide frac-
tions were hydrolyzed in 2 M trifluoroacetic acid for 3 h at
100°C. The resulting monosaccharides were separated and
quantified by high-pH anion exchange chromatography with
pulsed amperometric detection as previously described (28).
To determine linkages of the various sugars, partially methyl-
ated alditol acetates were prepared from the oligosaccharide
fraction as described in detail elsewhere (28). Briefly, NaOH
was used with dimethyl sulfoxide to prepare the correspond-
ing alkoxide oligosaccharides, which were then methylated
with CH3I, hydrolyzed, reduced with sodium borodeuteride
(NaBD4), and acetylated (17). The resulting partially methyl-
ated alditol acetates were analyzed by gas chromatography-
mass spectrometry with a VG-70 mass spectrometer coupled to
a 30-m DB-1 capillary column (J&W Scientific). A tempera-
ture program of 120 to 250°C at 4°C/min was used with
electron impact detection (70 eV, 500 R.A trap current, 2 mA
emission current, and 180°C source temperature). A partially
methylated alditol acetate mixture obtained from the purified
major oligosaccharide of Salmonella typhimurium Ra lipopoly-
saccharide (Sigma) was used as a standard for correlating
retention times.
Mass spectrometry. To determine the molecular weights of
the LOS species and assess the heterogeneity of LOS glyco-
forms from both the wild type and pyocin variant, LOS were
analyzed by electrospray ionization mass spectrometry (ESI-
MS) after 0 deacylation with mild hydrazine (9). We have
found that 0 deacylation of LOS greatly increases its water
solubility and reduces its tendency to aggregate, making it
more amenable to direct analysis by ESI-MS techniques. To
prepare 0-deacylated LOS, approximately 1 mg of LOS from
strains 188 and 188-2 was suspended in 0.2 ml of hydrazine and
heated at 37°C for 20 min. 0-deacylated LOS was precipitated
with cold acetone, washed three times, and taken up in 0.5 ml
of water and lyophilized. For ESI-MS analysis, the lyophilized
0-deacylated LOS samples were dissolved in water and in-
jected into a stream of H2O-CH3CN (3:1) containing 1% acetic
acid as previously described (8). Mass spectra were taken in the
negative-ion mode on a VG/Fison BioQ triple quadrupole
mass spectrometer operating in the negative-ion mode with a
constant flow rate of 3 pul/min. Mass spectra were then
averaged and masses were assigned via the VG/Fison data
system by using an external calibrant. Average LOS molecular
weights were calculated by adding the molecular weight of the
conserved diphosphoryl diacyl lipid A moiety, 953.0089, to the
interval average mass values of the monosaccharide and phos-
phate constituents: hexose (Hex), 162.1424; heptose (Hep),
192.1687; N-acetylhexosamine (HexNAc), 203.1950, 3-deoxy-
D-manno-octulosonic acid (Kdo), 220.1791; 5-N-acetylneur-
aminic acid (sialic acid or Neu5Ac), 291.2579; phosphoethanol-
amine (PEA), 123.0483; and phosphate (P), 79.9799.
The following analyses were used to confirm the composi-
tion assignments of the oligosaccharide portions of these LOS,
as suggested from monosaccharide and ESI-MS data. The
oligosaccharide fractions from 188 and 188-2 LOS were sepa-
rately analyzed by negative-ion liquid secondary ion mass
spectrometry (LSIMS) on a Kratos MS50S mass spectrometer
(28). LSIMS analysis of the oligosaccharides affords a higher
degree of mass accuracy (+0.3 Da) than ESI-MS experiments
and can also provide limited sequence information through the
presence of fragment ions.
Oligosaccharides were dissolved in water, and small aliquots
("2 to 5 jig) were transferred to the LSIMS probe along with
1 ,ul of thioglycerol-glycerol (1:2, vol/vol). A Cs+ beam of 10
keV was used, and the resulting ions were accelerated at 8 keV.
Spectra were taken at 300 s per decade and manually cali-
brated to an accuracy of better than ±0.2 Da with an external
Ultramark calibrant. Since the MS50S mass spectrometer is
run under conditions that resolve the isotopic distribution of
the various ions (M/AM 2,000), masses are reported as their
most abundant isotopically pure component. To calculate the
"2C-containing molecular ions, the following exact interval mass
values were used: Hex, 162.0528; Hep, 192.0634; HexNAc,
203.0794, Kdo, 220.0583; anhydroKdo, 202.0477; NeuSAc,
291.0954; PEA, 123.0085; and H20, 18.0106.
RESULTS
Pyocin selection and LOS analyses. After initial determina-
tions of pyocin sensitivity (Table 1), pyocin N was selected for
use in these studies. Pyocin N was used on H. ducreyi 35000,
27722, 023233, CIP542, and 188 strains. Of these strains, 12
colonies were isolated from the zones of lysis: 3 from strain
35000, 2 from strain 023233, and 7 from strain 188. These
colonies were expanded in culture, and the identities of the
strains were confirmed as described in Materials and Methods.
The LOS preparations from each colony were compared with
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FIG. 1. SDS-PAGE on a 14Cc tricine gel. Lane 1, purified LOS
from H. ducreyi 188; lane 2, LOS from pyocin-selected H. dulcreyi 188-2.
The molecular mass markers are 16.9 (a), 14.4 (b), 8.1 (c), and 6.2 (d)
kDa.
the parental LOS profile by SDS-PAGE and silver stain
technique as described previously (10, 33). The results indi-
cated that one isolated colony, from strain 188, appeared to
assemble an LOS with a different SDS-PAGE banding pattern.
Figure 1 is a silver stain of a tricine gel illustrating that the LOS
from pyocin survivor isolate 2 (lane 2) had a more rapidly
migrating electrophoretic banding pattern than the parental
strain 188 (lane 1). It appears that the LOS from this pyocin N
survivor, termed 188-2, is a truncated version of the major LOS
species assembled by H. ducreyi 188.
Colony blot studies with MAb 3F11. Our previous studies
have shown that MAb 3F11 reacts with a 4.8-kDa LOS band
present on 97% of the H. ducreyi strains in our collection. On
the basis of the LOS SDS-PAGE profile of pyocin survivor
188-2, we performed colony lifts and probed these with MAb
3F 11. Figure 2 shows an example of a colony lift in which MAb
3F1 1 reacted to H. dulcreyi 188 (panel A) but not to the
pyocin-selected strain 188-2 (panel B). These data suggest that
H. diucreyi 188-2 has lost all or part of the terminal trisaccha-
ride present on the native LOS. Repeated passage and selec-
tion of H. dutcreyi 188-2 have shown that this LOS variant
appears to be stable.
Electrospray analysis of 0-deacylated LOS. The ESI-MS
spectra of the 0-deacylated LOS from strains 188 and 188-2
shown in Fig. 3 indicated that a substantial change to a much
simpler and less heterogeneous LOS mixture had occurred in
the pyocin survivor. In contrast, the spectrum of the parent
strain 188 contained many of the same peaks previously
reported for H. ducreyi 35000 (22) but was considerably more
heterogeneous. For example, the ESI-MS spectrum of 0-
deacylated LOS from the parental H. dlccreyi strain (Fig. 3A)
clearly shows two dominant triply charged peaks at m/z 943.6
and 1,041.6, as well as their anhydro counterparts at m/z 938.2
and 1,034.7, corresponding to the average molecular weights of
2,833.4 (LOS L) and 3,127.8 (LOS N), respectively (Table 2).
These are similar to the two major components observed
earlier for strain 35000 (22), which were found to differ by the
presence or absence of sialic acid (Am 291 Da). However, a
multitude of less abundant secondary peaks, the bulk of which
appear also to be triply charged ions, were also present. These
peaks can mostly be assigned as LOS components containing
an additional PEA moiety, and/or sequential saccharide dele-
tions down to a conserved Hep3Kdo(P)-O-deacyl lipid A core
(i.e., LOS A, Mr of 1,830.3) (Table 2).
The ESI-MS spectrum of the 0-deacylated LOS from H.
ducreyi 188-2 contained peaks which correspond to a relatively
A
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FIG. 2. Colony lift assays of
probed with MAb 3F1 1.
0
*_ ::
-
H. dIucrevi 188 (A) and 188-2 (B)
simple series of related LOS components with mostly smaller
molecular weights. The most abundant LOS form is evident as
a triply charged ion, (M-3H)3 at mn/z 822.3, and much less
abundant is a doubly charged ion, (M-2H)2- at mn/z 1,233.6.
Taken together, this pair of ions yields an average Mr of 2,469.5
for this major component, LOS C. Curiously, this spectrum is
essentially devoid of peaks originating from a loss of water, i.e.,
anhydro LOS forms, which mostly dominated the spectrum of
the parental LOS mixture. In addition to the dominant LOS C
from 188-2, there are two other LOS species of lower mass
whose molecular weights are consistent with the loss of a single
heptose (LOS A, Mr of 2,276.8) or hexose (LOS B, Mr of
2,307.3) and two species of higher masses consistent with the
addition of PEA (LOS D, Mr of 2,592.0) or Hex and HexNAc
(LOS E, Mr of 2,712.7). This latter component may represent
a very small amount of full-length parental LOS (<3%) in the
total LOS preparation. Despite the complexity and heteroge-
neity observed in the wild-type strain, if one considers only the
difference between the most abundant LOS forms in each
preparation, i.e., parental LOS N and the pyocin variant LOS
C, it is evident that the pyocin variant has undergone a
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938.2
883.2
848.7 J
775.6
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1034.7
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FIG. 3. Negative-ion ESI-MS of the 0-deacylated H. ducreyi LOS from the parental strain 188 (A) and the pyocin-variant strain 188-2 (B). See
Table 2 for the assignments of these ions to specific LOS composition groups. Because the complexity observed in the ESI-MS spectrum of 188,
only triply charged ions are labeled, e.g., A3 = (MA-3H)3-, A*3 = (MA-H20-3H)3-, and B3 = (MB-3H)3 , etc. Other doubly and possibly
quadruply charged species also exist but are much less abundant and often overlap with the triply charged components.
trisaccharide deletion consisting of hexose, N-acetylhex-
osamine, and sialic acid but has picked up an additional PEA
moiety.
Structural analysis of oligosaccharides. To obtain addi-
tional structure information supporting this conclusion, the
oligosaccharide fractions from the LOS of both the parental
strain and the pyocin N survivor were subjected to LSIMS
analysis. As shown in Fig. 4A for the parental H. ducreyi strain,
the base peak appears as the singly deprotonated molecular
ion peak, (M-H)- at m!z 1,676. (Masses for LSIMS are
reported as their nominal mass equivalents unless otherwise
noted, i.e., m/z 1,676 is 1,676.5.) A second molecular ion peak of less
INFECT. IMMUN.
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TABLE 2. ESI-MS analyses of 0-deacylated LOS
H. ducrevi Mr Relative ion P c
strain and LOS Observed Calculated abundanceh
Parent 188
A/A*, 1,830.3/1,811.0 1,829.7/1,811.6 13 HeP3 Kdo(P) lipid Ad
B/B* 1,953.6/1,934.7 1,952.7/1,934.7 37 HeP3 PEA Kdo(P) lipid A
C/C* 1,991.1/1,970.7 1,991.8/1,973.8 (5) Hex HeP3 Kdo(P) lipid A
D/D* 2,115.0/(2,097.3) 2,114.8/2,096.8 (4) Hex HeP3 PEA Kdo(P) lipid A
E/E* 2,181.6/(2,166.0) 2,184.0/2,166.0 (2) Hex HeP4 Kdo(P) lipid A
F/F* (2,305.8)/2,291.4 2,307.0/2,289.0 18 Hex HeP4 PEA Kdo(P) lipid A
G/G* (2,346.0)/2,329.8 2,346.1/2,328.1 26 HeX2 HeP4 Kdo(P) lipid A
H/H* 2,469.0/2,449.2 2,469.2/2,451.1 13 Hex2 HeP4 PEA Kdo(P) lipid A
1/1* 2,549.1/2,533.2 2,549.3/2,531.3 41 HexNAc HeX2 Hep4Kdo(P) lipid A
J/J* 2,673.0/2,652.6 2,672.4/2,654.3 49 HexNAc HeX2 HeP4 PEA Kdo(P) lipid A
K/K* 2,713.8/2,691.6 2,711.4/2,693.4 46 HexNAc HeX3 HeP4 Kdo(P) lipid A
L/L* 2,833.8/2,817.6 2,834.5/2,816.5 98 HexNAc HeX3 HeP4 PEA Kdo(P) lipid A
M/M* 3,002.4/2,981.4 3,002.7/2,984.7 46 NeuAc HexNAc HeX3 HeP4 Kdo(P) lipid A
N/N* 3,127.8/3,107.1 3,125.8/3,107.7 100 NeuAc HexNAc HeX3 HeP4 PEA Kdo(P) lipid A
Variant 188-2
A 2,276.8 2,277.0 10 HeX2 HeP3 PEA Kdo(P) lipid A
B 2,307.3 2,307.0 29 Hex HeP4 PEA Kdo(P) lipid A
C 2,469.5 2,469.2 100 HeX2 HeP4 PEA Kdo(P) lipid A
D 2,592.0 2,592.2 10 HeX2 HeP4 PEA2 Kdo(P) lipid A
E 2,712.7 2,711.4 (4) HexNAc HeX3 Hep4 Kdo(P) lipid A
All molecular weights are reported as their average mass values, based on the triply charged ions.
" Relative abundances are based solely on the triply charged ion species for strain 188 because of difficulties in assigning ions charged doubly and quadruply as a result
of spectral peak overlap. Numbers in parentheses are considered near the limits of detection.
C Asterisk refers to LOS components which have lost H2O.
d After 0 deacylation, the lipid A moiety is converted into diphosphoryl diacyl lipid A containing two N-linked f3-hydroxymyristic acid chains with an average Mr of
953.0089.
abundance is also observed at m/z 1,514, which is consistent with the
loss of a (terminal?) hexose from the more abundant molecular
ion at m/z 1,676. These masses are in excellent agreement with
the expected compositions of Hex3HexNAcHep4anhydroKdo and
Hex2HexNAcHep4anhydroKdo. These generic composition assign-
ments are also supported by monosaccharide composition
analyses as listed in Tables 3 and 4. For the parent strain 188,
relative compositions of approximately 2:1:1 for Gal/Glc/Glc-
NH2 were found, in addition to an estimated relative compo-
sition of approximately 2:1 for L-glycero-D-manno-heptose and
D-glycero-D-manno-heptose. As previously observed, Kdo was
not seen in the composition analysis because of its conversion
to anhydroKdo from phosphorylated Kdo (9, 22, 26, 27). The
assignment of phosphorylated Kdo is also supported by the
molecular weight data and the triply charged states observed
under negative-ion ESI-MS (Table 2). These data can only be
explained through the presence of three unsubstituted phos-
phates (z = -3), two of which can be accounted for in the
conserved diphosphoryl lipid A, and the remaining phosphate
on the oligosaccharide portion. Since neither phosphate nor
Kdo was found in the hydrolyzed oligosaccharides, and the
mass of the oligosaccharide was 18 Da lower than would be
expected if unmodified Kdo were present, we can conclude
that Kdo was initially present in its phosphorylated form. The
conversion of phosphorylated Kdo to anhydroKdo during
acetic acid hydrolysis has been previously noted by ourselves
and others in the LOS from several Haemophilus strains (22,
26).
In addition to the two molecular ions identified in the
LSIMS spectrum ofH. ducreyi 188, some limited fragmentation
is present in the form of the glycosidic Y- and Z-type fragment
ions (6). For instance, fragment ions arising from cleavage at
either side of the glycosidic oxygen with charge retention at the
reducing terminus are seen at m/z 1,311 and 1,293 (loss of
HexNAc,Hex), m/z 1,149 and 1,131 (loss of HexNAc,Hex2),
and m/z 957 and 939 (loss of HexNAc,Hex2,Hep). These fragment
ions allowed the partial sequence of the main nonreducing branch to
be assigned as Hex-sHexNAc---Hex->Hep. Overall, this leaves
Hex, Hep3, and anhydroKdo as the remaining undetermined
core oligosaccharides in the parent strain. Tandem mass
spectrometry of the most abundant parent ion at m/z 1,676
yielded a spectrum that was identical to the one previously
reported for the major oligosaccharide from strain 35000 (data
not shown) (22). These data, therefore, allowed a more
complete structural assignment for this oligosaccharide:
Hex->HexNAc--Hex-sHep---Hex--sHep-*anhydroKdo
I
Hep->Hep
Linkage analysis of strain 188 revealed eight major sugars
eluting in the following order: terminal Gal, 3-Gal, 6-Glc,
terminal Hep, 4-Hep, 2-Hep, 3,4-Hep, and 4-GlcNAc (Tables
3 and 4). These sugars were the same as those previously found
in the major oligosaccharide from H. ducreyi 35000 (22).
Moreover, the presence of a terminal galactose and a 4-linked
N-acetylglucosamine can be unambiguously assigned to the
terminal branch, on the basis of the LSIMS oligosaccharide
fragmentation data, as Gall->4GlcNAc. Given the previously
reported high level of binding of MAb 3F1 1 to the LOS of this
parent strain (3), this terminal structure is likely to be
Gall3--4GlcNAc, or terminal lactosamine. If H. ducreyi 188
LOS were to contain the same oligosaccharide as that previ-
ously proposed for H. ducreyi 35000 (22), the full structure
would be:
GalB 1-4GlcNAc,B1 -3Gal, 1-4HepoI-16GlcI 1 -s4Hepot1 -sanhydroKdo
3
Hepot -12Hepc I
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FIG. 4. Negative-ion LSIMS spectra of the oligosaccharide fractions obtained by acetic acid hydrolysis of the LOS. (A) Wild-type parental
strain 188, (M-H)- at m/z 1,676 and 1,514. (B) Pyocin-variant strain 188-2, (M-H)- at m/z 1,434 and 1,272. (C) Dephosphorylated pyocin-variant
strain 188-2, (M-H)- at m/z 1,311 and 1,149. Kdo, anhydroKdo.
The LSIMS spectrum of the oligosaccharide from the pyocin
survivor, strain 188-2, contains a much smaller oligosaccharide ofMr
1,434, as shown in Fig. 4B. This mass is in agreement with an
oligosaccharide composition of Hex2,Hep4,PEA,anhydioKdo. PEA
had previously been assigned to the composition of this LOS
on the basis of the ESI-MS molecular weight data (Table 2).
Treatment of the oligosaccharide with aqueous hydrogen
fluoride (HF) to remove phosphoester moieties and analysis by
LSIMS gave the spectrum shown in Fig. 4C. Fragment ions in
the LSIMS spectrum at m/z 1,119 and m/z 1,149 and 957 can be
interpreted as arising from glycosidic bond cleavages originat-
TABLE 3. Oligosaccharide composition
Mole ratio relative to glucose'
Strain
Galactose Glucose Heptose Heptoseb GlcNH2
188 1.5 1.0 2.0 1.1 0.8
188-2 0.8 1.0 2.8 0.1
a Kdo was not detected in the hydrolyzed oligosaccharide fraction because of
its conversion to anhydroKdo forms during acetic acid hydrolysis of LOS.b This second heptose has been tentatively identified as D-glycero-D-manno-
heptose on the basis of earlier data (22), as opposed to the major core heptoses
which are L-glycero-D-manno-heptoses.
ing from two separate nonreducing terminal branches, Hep
and Hex->Hep, respectively. Therefore, the LOS of the H.
ducreyi pyocin variant 188-2 clearly lacks the terminal lac-
tosamine structure that endows the parent strain with the
acceptor for sialylation, as well as the epitope for MAb 3F11
binding (Fig. 5). Tandem mass spectrometry data on this
oligosaccharide supported the argument for this overall struc-
ture, as well as determining the linkage of PEA to heptose, but
otherwise did not contain any additional information (data not
shown). These structural data strongly suggest that H. ducreyi
188-2 synthesizes an LOS with a truncated oligosaccharide
TABLE 4. Oligosaccharide methylation analysis
Relative peak area'
Strain
t-Gal 3-Gal 6-Glc t-Hep 2-Hep 3,4-Hep 4-Hep 4-GlcNAc
188 1.0 0.6 1.8 0.5 0.7 0.3 0.6 1.1
188-2 1.0 1.5 0.3/1.3b 1.3 0.4
a Partially methylated alditol acetates are abbreviated according to their
substitution patterns as follows: t-Gal is 1,5-di-O-acetyl-2,3,4,6-tetra-O-methyl-
galactitol and 3-Gal is 1,3,5-tri-O-acetyl-2,4,6-tri-O-methylgalactitol, etc.
b Two terminal heptoses were found, the ratio stated is the unusual D-glycero-
D-manno-heptose to the expected terminal core L-glycero-D-manno-heptose.
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FIG. 5. Proposed structural differences between the LOS expressed
by H. ducreyi 188 (A) and pyocin variant 188-2 (B). The major LOS
species present in each strain (solid lines) are represented. The terminal
lactosamine (Gal l-4GlcNAc) site is also indicated for the minimal epitope
required for MAb 3F1 1 binding, which may extend to the 3-linked galactose
(GalI4GlcNAcB1-3Gal) as a further mimicry of the human paraglobo-
side structure, Gall1--4GlcNAcl1---3Gal,l1--4Glc. In addition to the ter-
mination sites shown in the 188-2 structure, a third LOS variant exists,
as indicated by ESI-MS data, that differs from the major 188-2 LOS C
by having three heptoses instead of four, suggesting that this variant is
capable of synthesizing a Hex2 branch off the core Hep3 region which
bypasses the branch D-glycero-D-manno-heptose (Hep*, see above),
i.e., Hex-Hex-HepNKdo(P)-lipid A.
branch terminating prior to the formation of the lactosamine
disaccharide. However, the LOS of the pyocin N survivor also
contain at least one PEA group in the core heptose region and
therefore differs further from the parent strain, which contains
either one or none at all. Composition and methylation
analyses of H. ducreyi 188-2 also support these interpretations
(Tables 3 and 4). Further structural studies will be needed,
however, to fully determine the complete LOS structures
present in both the parent and pyocin-variant strains.
DISCUSSION
Although the exact mechanism by which pyocin acts remains
undefined, previous studies with N. gonorrhoeae have sug-
gested that pyocin binds to LOS on the surface of the outer
membrane (7, 24). Moreover, the electrospray mass spectral
analysis of the pyocin-derived gonococcal LOS variants 1291a
through 1291, has shown that pyocins can select for organisms
which express a truncated LOS structure (11). The generation
of LOS variants from other enteric and nonenteric human
pathogens has also been shown to be extremely useful in
delineating the structure of these complex glycolipids and can
be an effective means to relate structure to biologic function
(18, 19). In this study, we have used the same strategy to isolate
H. ducreyi 188-2, a pyocin N survivor, from the parental strain
188. Moreover, repeated passage of strain 188-2 on chocolate
agar has not demonstrated any reversion back to the parental
LOS phenotype, suggesting that H. duicreyi 188-2 is stable.
Biochemical and mass spectral analyses demonstrated that
H. ducreyi 188-2 assembles a set of truncated LOS structures.
Mass spectrometric, composition, and linkage studies of this
structure revealed that the variant LOS no longer expresses the
terminal lactosamine present on the LOS of H. ducreyi 188.
These data were confirmed by immunologic studies which
show that colonies of H. ducreyi 188-2 have lost reactivity with
MAb 3F1 1 (Fig. 2).
The epitope recognized by MAb 3Fl 1 has important patho-
genic implications for the success of N. goniotrrhoeae. Previous
studies by Mandrell and colleagues have shown that the
epitope recognized by this antibody is identical to that found
on the terminal tetrasaccharide of paragloboside, a glycosphin-
golipid precursor of the major human blood group antigen
which terminates in the disaccharide, N-acetyllactosamine
(20). Parsons and coworkers have shown that gonococci grown
in the presence of CMP-N-acetylneuraminic acid, modify their
LOS structure by the addition of N-acetylneuraminic acid (or
sialic acid) and consequently become more serum resistant
(25). Subsequent studies have demonstrated that the terminal
galactose residue of the gonococcal LOS epitopes serves as the
acceptor for sialic acid (21). Immunoelectron microscopic
studies of infected urethral exudates have shown the presence
of sialylated and nonsialylated LOS moieties during natural
gonococcal infection (2).
The LOS assembled by H. ducreyi 188-2 lack the terminal
trisaccharide present in strain 188. The absence of sialic acid in
the LOS preparations of strain 188-2, versus the presence of
sialic acid detected on H. ducreyi 188, suggests that the
terminal lactosamine structure may serve as the acceptor site
for sialylation in this organism. It has been suggested that an
important function of the glycosphingolipid-like structures
may be in short-range attachment to and uptake by human
cells (5). Indeed, an increasing body of evidence which indi-
cates that H. ducreyi can adhere to and possibly invade human
epithelial cells is gathering (14, 15). However, more studies are
needed to determine whether the LOS or the presence of sialic
acid has a role in this phenomenon.
In this report, we have demonstrated that H. dlucreyi strains
are susceptible to pyocin lysis. We have used pyocin selection
to generate a stable H. ducreyi variant which assembles a
truncated LOS structure different from the major LOS species
synthesized by parent strain 188. Further biologic studies of H.
ducreyi 188 and 188-2 and purified LOS from each strain may
provide some insight as to the importance of sialylation and the
role of H. ducreyi LOS in the pathogenesis of genital ulcer
disease.
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